Valproic acid therapy for complex partial seizures. Its efficacy and toxic effects

Area of Science:

• Neurology
• Pharmacology

Background:

• Complex partial seizures (CPS) are a common form of epilepsy.
• Effective long-term management of poorly controlled CPS remains a clinical challenge.

Purpose of the Study:

• To evaluate the efficacy and tolerability of valproic acid in adult outpatients with poorly controlled complex partial seizures.
• To assess the development of tolerance to valproic acid over time.

Main Methods:

• A prospective study involving 24 adult outpatients with poorly controlled CPS.
• Valproic acid was added to existing antiepileptic drug regimens to maintain stable plasma levels.
• Seizure frequency and adverse events were monitored.

Main Results:

• Initially, 12 patients (50%) experienced >50% seizure reduction.
• Only five patients maintained long-term benefit; seven developed tolerance to valproic acid's efficacy.
• Weight gain (14/17 patients), nausea (18/24 patients), and postural tremor (5/24 patients) were the most common adverse events.
• No hepatotoxicity or hematological abnormalities were observed.

Conclusions:

• Valproic acid provides initial seizure reduction in some patients with poorly controlled CPS.
• Tolerance to valproic acid efficacy can develop, limiting long-term benefit.
• Valproic acid is generally well-tolerated, with mild adverse effects predominating, but its long-term efficacy is variable.